Background: Off-label dosing of direct oral anticoagulants (DOACs) is both common and associated with adverse patient outcomes. Evidence describing best practices to support optimal direct oral anticoagulant (DOAC) dosing is limited. Objective: To describe the impact of clinical pharmacist intervention on DOAC prescribing. Methods: This retrospective study was a descriptive analysis conducted within an integrated healthcare system with a centralized, pharmacist-led Anticoagulation Management Service (AMS). Patients prescribed a DOAC between January 1, 2020 and December 31, 2020 were included. Pharmacy dispensing reports were generated for pharmacist review and anticoagulant drug therapy changes were recommended to physicians where appropriate. The primary objective was to describe the number and type of recommendations made. Secondary objectives were to determine the provider acceptance rate based on the intervention type and on clinical vs formulary recommendations. Results: Clinical pharmacists made 147 recommendations for 2331 unique patients included in the analysis. Twenty-three recommendations (16%) were to decrease the dose, 46 (31%) were to increase the dose, 14 (10%) were to change the medication due to clinical scenario, 62 (42%) were to change the medication due to cost, and 2 (1%) were another issue. One hundred twenty-three (84%) recommendations were accepted. The provider acceptance rate was similar for clinical and formulary recommendations (85% and 82% respectively). Conclusion: Implementation of report-driven clinical pharmacist intervention led to an improvement in appropriate DOAC medication selection and dosing.
National Blood Clot Alliance. Bleeding Risk Survey. IBM Truven Health Analytics, 12 Months Ending December 31, 2018 for Commercial, Medicare and Medicaid Patients; October 24, 2019. Accessible at: https://www.stoptheclot.org/news/bleeding-risk-survey/
2.
AlmutairiARZhouLGelladWF, et al.Effectiveness and safety of non–vitamin K antagonist oral anticoagulants for atrial fibrillation and venous thromboembolism: a systematic review and meta-analyses. Clin Therapeut. 2017;39(7):1456-1478.
3.
ShehabNLovegroveMCGellerAIRoseKOWeidleNJBudnitzDS. US emergency department visits for outpatient adverse drug events, 2013–2014. JAMA. 2016;316(20):2115-2125.
4.
BarnesGDLucasEAlexanderGCGoldbergerZD. National trends in ambulatory oral anticoagulant use. Am J Med. 2015;128(12):1300-1305.
AshjianEKurtzBRennerEYesheRBarnesGD. Evaluation of a pharmacist-led outpatient direct oral anticoagulant service. Am J Health Syst Pharm. 2017;74(7):483-489.
8.
PerlmanAHorwitzEHirsh-RaccahB, et al.Clinical pharmacist led hospital-wide direct oral anticoagulant stewardship program. Isr J Health Pol Res. 2019;8:19.
9.
UppuluriEMMcCombMNShapiroNL. Implementation of a direct oral anticoagulation screening service at a large academic medical center provided by a pharmacist-managed antithrombosis clinic as a method to expand antithrombotic stewardship efforts. J Pharm Pract. 2020;33(3):271-275.
10.
SteinbergBAShraderPPieperK, et al.Frequency and outcomes of reduced dose non–vitamin K antagonist anticoagulants: results from ORBIT-AF II (the outcomes registry for better informed treatment of atrial fibrillation II). J Am Heart Assoc. 2018;7(4):e007633.
11.
KennedyJTuleuIMackayK. Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed. J Manag Care Pharm. 2008;14(6):553-560.
12.
SabatéE. Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization; 2003.
13.
OsterbergLBlaschkeT. Adherence to medication. N Engl J Med. 2005;353:487-497.
14.
YaoXShahNDSangaralinghamLRGershBJNoseworthyPA. Non–vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction. J Am Coll Cardiol. 2017;69(23):2779-2790.
15.
CarlinSPickeringJSchulmanS. Appropriateness of apixaban dosing to prevent stroke in patients with atrial fibrillation: a pilot study. Can J Hosp Pharm. 2016;69(6):449-453.
16.
AhujaTRacoVPapadopoulosJGreenD. Antithrombotic stewardship: assessing use of computerized clinical decision support tools to enhance safe prescribing of direct oral anticoagulants in hospitalized patients. J Patient Saf. 2021;17(8):e1057-e1061.
17.
SelcukASancarMOkuyanBDemirtuncRIzzettinFV. The potential role of clinical pharmacists in elderly patients during hospital admission. Pharmazie. 2015;70(8):559-562.
18.
SaokaewSSapooUNathisuwanSChaiyakunaprukNPermsuwanU. Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand. Int J Clin Pharm. 2012;34(1):105-112.
